Management of antibiotic allergy in children: a practical approach

Main Article Content

Nikolaos Kitsos
Dimitrios Cassimos
Ioannis Xinias
Charalampos Agakidis
Antigoni Mavroudi

Keywords

allergy, children, drug, graded challenge, skin test

Abstract

Background: About 10% of children are declared as allergic to antibiotics, with beta(β)-lactams being the most common perpetrators. However, few of these are confirmed by allergy tests. This characteristic of being allergic follows a child well into adulthood, leading to alternative, usually more expensive broad-spectrum antibiotics, contributing to antibiotic resistance and increasing healthcare expenses.


Objective: This review presents a practical approach to managing pediatric patients with antibiotic hypersensitivity reactions.


Material and methods: We updated the guidelines on antibiotic allergy in children by conducting systematic literature research using the best available evidence from PubMed search by entering the keywords “antibiotic allergy” and “children.” The search output yielded 5165 citations.


Results: Management of antibiotic allergy depends on the culprit antibiotic, and it includes confirmation of the diagnosis and finding a safe alternative to the culprit antibiotic. In particular patients with a history indicative of penicillin allergy can be treated with cephalosporins as an alternative to penicillin, especially with third-generation cephalosporins, except for those with similar R1 side chains. In patients with a history of immediate-type reactions to cephalosporins who require treatment with cephalosporins or penicillin, skin tests with cephalosporin or penicillin with different side chains should be performed. If allergy to macrolides is suspected, challenge tests are currently the only reliable diagnostic tool. The best strategy for managing patients with sulfonamide hypersensitivity is an alternative antibiotic. The skin prick tests and intradermal tests are not recommended for diagnosis of quinolone allergy, as they can activate dermal mast cells leading to false-positive results. Quinolone challenge test is the most appropriate test for diagnosing quinolone hypersensitivity.


Conclusion: Although adverse drug reactions to antibiotics are frequently documented, immunologically mediated hypersensitivity is unusual. In the event of an reaction, an appropriate diagnostic workup is required to identify the drug’s causal role. It is critical to avoid “labeling” a child as allergic without first conducting a proper diagnostic workup.

Abstract 727 | PDF Downloads 685 HTML Downloads 166 XML Downloads 62

References

1. Smyth RM, Garrgon E, Kirkham J, Cresswell L, Golder S, Smyth R, et al. Adverse drug reactions in children—A systematic review. PLoS One. 2012;7(3):e24061. 10.1371/journal.pone.0024061

2. Clavenna A, Bonati M, Adverse drug reactions in childhood: A review of prospective studies and safety alerts. Arch Dis Child. 2009;94(9):724–8. 10.1136/adc.2008.154377

3. Macy E, Poon K-Y T. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med. 2009;122(8):778.e1–7. 10.1016/j.amjmed.2009.01.034

4. Seitz CS, Brocker EB, Trautmann A. Diagnosis of drug hypersensitivity in children and adolescents: Discrepancy between physician-based assessment and results of testing. Pediat Allergy Immunol. 2011;22(4):405–10. 10.1111/j.1399-3038.2011.01134.x

5. Vezir E, Erkocoglu M, Civelek E, Kaya A, Azkur D, Akan A, et al. The evaluation of drug provocation tests in pediatric allergy clinic: a single center experience. Allergy Asthma Proc. 2014;35(2):156–62. 10.2500/aap.2014.35.3744

6. Macy E, Romano A, Khan D. Practical management of antibiotic hypersensitivity in 2017. J Allergy Clin Immunol Pract. 2017;5(3):577–86. 10.1016/j.jaip.2017.02.014

7. Sacco KA, Bates A, Brigham TJ, Imam JS, Burton MC. Clinical outcomes following inpatient penicillin allergy testing: A systematic review and meta-analysis. Allergy. 2017;72(9):1288–96. 10.1111/all.13168

8. Li M, Krishna KA, Razaq S, Pillay D A real-time prospective evaluation of clinical pharmaco-economic impact of diagnostic label of “penicillin allergy” in UK teaching hospital. Clin Pathol. 2014;67:1088–92. 10.1136/jclinpath-2014-202438

9. Sousa-Pinto B, Cardoso-Fernandes A, Araujo L, Fonseca JA, Freitas A, Delgado L. Clinical and economic burden of hospitalizations with registration of penicillin allergy. Ann Allergy Asthma Immunol. 2018;120(2):190–4.e2. 10.1016/j.anai.2017.11.022

10. Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51–77. 10.1093/cid/ciw118

11. Jeffres MN, Narayanan PP, Shuster JE, Schramm GE. Consequences of avoiding belactams in patients with belactam allergies. J Allergy Clin Immunol Pract. 2016;137:1148–53. 10.1016/j.jaci.2015.10.026

12. Trubiano JA, Grayson ML, Thursky KA, Phillips EJ, Slavin MA. How antibiotic allergy labels may be harming our most vulnerable patients. Med J Aust. 2018;208:469–70. 10.5694/mja17.00487

13. Norton AE, Konvinse K, Phillips EJ, Broyles AD. Antibiotic allergy in pediatrics. Pediatrics. 2018;141(5):e20172497. 10.1542/peds.2017-2497

14. Ponvert C, Perrin Y, Bados-Albiero A, Le Bourgeois M, Karila C, Delacourt C, Scheinmann P, De Blic J. Allergy to beta-lactam antibiotics in children: Results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol. 2011;22:411–8. 10.1111/j.1399-3038.2011.01169.x

15. Trubiano JA, Stone CA, Grayson ML, Urbancic Κ, Slavin MA, Thursky KA, et al. The 3Cs of antibiotic allergy-classification, cross-reactivity, and collaboration. J Allergy Clin Immunol Pract. 2017;5(6):1532–42. 10.1016/j.jaip.2017.06.017

16. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization. J Allergy Clin Immunol. 2004;113(5):832–6. 10.1016/j.jaci.2003.12.591

17. Tien F. Drug hypersensitivity. Med J Aust. 2006;185:333–8. 10.5694/j.1326-5377.2006.tb00591.x

18. Caubet JC, Kaiser L, Lemaitre B, Fellay B, Gervaix A, Eigenmann PA. The role of penicillin in benign skin rashes in childhood: A prospective study based on drug rechallenge. J Allergy Clin Immunol. 2011;127(1):218–22. 10.1016/j.jaci.2010.08.025

19. Caimmi D, Bernardini R, Caffarelli C, Crisafulli G, Pingitore G, Marseglia GL. Perioperative anaphylaxis: epidemiology. Int J Immunopathol Pharmacol. 2011;24:S21–6. 10.1177/03946320110240S304

20. Gomez, Miguel Blanca Torres Maria J, Mayorga Critobalina, Perez-Inestrosa Ezequiel, Suau Rafael, Montañez Maria I, Juarez, Carlos Immediate allergic reactions to betalactam: Facts and controversies. Curr Opin Allergy Clin Immunol. 2004;4:261–6. 10.1097/01.all.0000136764.74065.15

21. Keighley CL, Saunderson RB, Kok J, Dwyer DE. Viral exanthems. Curr Opin Infect Dis. 2015;28(2):139–50. 10.1097/QCO.0000000000000145

22. Caffarelli C, Cuomo B, Cardinale F, Barberi S, Dascola CP, Agostinis F, et al. Aetiological factors associated with chronic urticaria in children: A systematic review. Acta Derm Venereol. 2013;93(3):268–72. 10.2340/00015555-1511

23. Caffarelli C, Dascola CP, Peroni D, Ricò S, Stringari G, Varini M, et al. Airway acidification in childhood asthma exacerbations. Allergy Asthma Proc. 2014;35:51–6. 10.2500/aap.2014.35.3740

24. Macy E, Ho NJ. Multiple drug intolerance syndrome: Prevalence, clinical characteristics, and management. Ann Allergy Asthma Immunol. 2012;108(2):88–93. 10.1016/j.anai.2011.11.006

25. Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. Drug allergy: An updated practice parameter. Ann Allergy Asthma Immunol. 2010 Oct;105(4):259–273. 10.1016/j.anai.2010.08.002. PMid: 20934625

26. Posadas SJ, Pichler WJ. Delayed drug hypersensitivity reactions—New concepts. Clin Exp Allergy. 2007;37(7):989–99. 10.1111/j.1365-2222.2007.02742.x

27. Zambonino MA, Corzo JL, Munoz C, Requena G, Ariza A, Mayorga C, et al. Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children. Pediatr Allergy Immunol. 2014;25(1):80–7. 10.1111/pai.12155

28. Banks TA, Ressner RA, Gada SM. Antibiotic reclamation: Penicillin allergy, antibiotic stewardship, and the allergist. Ann Allergy Asthma Immunol. 2015;115(5):451–2. 10.1016/j.anai.2015.08.008

29. Trubiano JA, Thursky KA, Stewardson AJ, Urbancic K, Worth LJ, Jackson C, et al. Impact of an integrated antibiotic allergy testing program on antimicrobial stewardship: A multicenter evaluation. Clin Infect Dis. 2017;65(1):166–74. 10.1093/cid/cix244

30. Gomes ER, Brockow K, Kuyucu S, Saretta F, Mori F, Blanca-Lopez N, et al. Drug hypersensitivity in children: Report from the pediatric task force of the EAACI Drug Allergy Interest Group. Allergy. 2016;71(2):149–61. 10.1111/all.12774

31. Mirakian R, Leech SC, Krishna MT, Richter AG, Huber PA, Farooque S, et al. Management of allergy to penicillins and other beta-lactams. Clin Exp Allergy. 2016;45(2):300–27. 10.1111/cea.12468

32. Wald ER, Applegate KE, Bordley C, Darrow DH, Glode MP, Marcy SM, et al. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics. 2013;132(1):e262–80. 2. 10.1542/peds.2013-1071

33. Esposito S, Cohen R, Domingo JD, Pecurariu OF, Greenberg D, Heininger U, et al. Do we know when, what and for how long to treat? Pediatr Infect Dis J. 2012;31:e78–85. 10.1097/INF.0b013e318255dc5b

34. Lieberthal AS, Carroll AE, Chonmaitree T, Ganiats TG, Hoberman A, Jackson MA, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131(3):e964–69. 10.1542/peds.2012-3488

35. Marchisio P, Bellussi L, Di Mauro G, Doria M, Felisati G, Longhi R, et al. Acute otitis media: From diagnosis to prevention. Summary of the Italian guideline. Int J Pediatr Otorhinolaryngol 2010;74(11):1209–16. 10.1016/j.ijporl.2010.08.016

36. Macy E, Blumenthal KG. Are cephalosporine safe for use in penicillin allergy without prior allergy evaluation? J Allergy Clin Immunol Pract. 2018;6(1):82–9. 10.1016/j.jaip.2017.07.033

37. Romano A, Gaeta F, Arribas Poves MF, Valluzzi RL. Cross-reactivity among beta-lactams. Curr Allergy Asthma Rep. 2016;16(3):24. 10.1007/s11882-016-0594-9

38. Zagursky RJ, Pichichero ME. Cross-reactivity in beta-lactam Allergy. J Allergy Clin Immunol Pract. 2018;6(1):72–81e1. 10.1016/j.jaip.2017.08.027

39. Chaudhry SB, Veve MP, Wagner JL. Cephalosporins: A focus on side chains and β-lactam cross-reactivity. Pharmacy (Basel). 2019;29(7):103. 10.3390/pharmacy7030103

40. Joint Task Force on Practice Parameter, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. Drug allergy: An update practice parameter. Ann Allergy Asthma Immunol. 2011;105:259–73. 10.1016/j.anai.2010.08.002

41. Macy E, Blumenthal KG. Are cephalosporins safe for use in penicillin allergy without prior allergy evaluation? J Allergy Clin Immunol Pract. 2018;6(1):82–9. 10.1016/j.jaip.2017.07.033

42. Gaeta F, Valluzzi RL, Alonzi C, Maggioletti M, Caruso C, Romano A. Tolerability of aztreonam and carbapenems in patients with IgE-mediated hypersensitivity to penicillins. J Allergy Clin Immunol. 2015;135(4):972–6. 10.1016/j.jaci.2014.10.011

43. Frumin J, Gallagher JC. Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics: What are the chances? Ann Pharmacother. 2009;43(2):304–15. 10.1345/aph.1L486

44. Blanca M, Romano A, Torres MJ, Fernandez J, Mayorga C, Rodriguez J, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy. 2009;64(2):183–93. 10.1111/j.1398-9995.2008.01924.x

45. Caffarelli C, Franceschini F, Caimmi D, Mori F, Diaferio L, Di Mauro D, et al. SIAIP position paper: Provocation challenge to antibiotics and non-steroidal anti-inflammatory drugs in children. Ital J Pediatr. 2018;44(1):147. 10.1186/s13052-018-0589-3

46. Kuyucu S, Mori F, Atanaskovic-Markovic M, Caubet JC, Terreehorst I, Gomes E, et al. Hypersensitivity reactions to non-beta-lactam antibiotics in children: An extensive review. Pediatr Allergy Immunol. 2014;25(6):534–43. 10.1111/pai.12273

47. Araujo L, Demoly P. Macrolides allergy. Curr Pharm Des. 2008;14(27):2840–62. 10.2174/138161208786369812

48. Grinlington L, Choo S, Cranswick N, Gwee A. Non-β-lactam antibiotic hypersensitivity reactions. Pediatrics. 2020;145(1):e2019-2256. 10.1542/peds.2019-2256

49. Barni S, Butti D, Mori F, Pucci N, Rossi ME, Cianferoni A, et al. Azithromicin is more allergenic than clarithromycin in children with suspected hypersensityvity reactions to macrolides. J Investig Allergol Clin Immunol. 2015;25(2):128–32.

50. Cavkaytar O, Karaatmaca B, Yilmaz E, Sekerel BE, Soyer O. Testing for clarithromycin hypersensitivity: A diagnostic challenge in childhood. J Allergy Clin Immunol Pract. 2016;4(2):330–2e1. 10.1016/j.jaip.2015.09.01

51. Mori F, Barni S, Pucci N, Rossi E, Azzari C, de Martino M, et al. Sensitivity and specificity of skin tests in the diagnosis of clarithromycin allergy. Ann Allergy Asthma Immunol. 2010;104(5):417–9. 10.1016/j.anai.2010.03.010

52. Broz P, Harr T, Hecking C, Grize L, Scherer K, Jaeger KA, et al. Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin. Allergy. 2012;67(5):647–52. 10.1111/j.1398-9995.2012.02807.x

53. Mori F, Pecorari L, Pantano S, Rossi ME, Pucci N, De Martino M, et al. Azithromycin anaphylaxis in children. Int J Immunopathol Pharmacol. 2014;27(1):121–6. 10.1177/039463201402700116

54. Sànchez-Borges M, Thong B, Blanca M, Ensina LFC, González-Díaz S, Greenberger PA,, et al. Hypersensitivity reaction to non-beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy. World Allergy Organ J. 2013;6:18. 10.1186/1939-4551-6-S1-P1810.1186/1939-4551-6-18

55. Galli E, Neri I, Ricci G, Baldo E, Barone M, Fortina AB, et al. Consensus conference on clinical management of pediatric atopic dermatitis. Ital J Pediatr. 2016;42:26. 10.1186/s13052-016-0229-8

56. Liippo J, Lammintausta K. Positive patch test reactions to gentamicin show sensitization to aminoglycosides from topical therapies, bone cements, and from systemic medication. Contact Dermatitis. 2008;59(5):268–72. 10.1111/j.1600-0536.2008.01419.x

57. Schnyder B, Pichler WJ. Allergy to sulfonamides. J Allergy Clin Immunol. 2013;131(1):256–7e1–5. 10.1016/j.jaci.2012.10.003

58. Chantachaeng W, Chularojanamontri L, Kulthanan K, Jongjarearnprasert K, Dhana N. Cutaneous adverse reactions to sulfonamide antibiotics. Asian Pac J Allergy Immunol. 2011;29:284–9.

59. Joint Task Force on Practice Parameters, American Academy of Allergy Asthma, Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. Allergen immunotherapy: A practice parameter second update. J Allergy Clin Immunol. 2007;120:S25–85. 10.1016/j.jaci.2007.06.019

60. Minhas JS, Wickner PG, Long AA, Banerji A, Blumenthal KG. Immune-mediated reactions to vancomycin: A systematic case review and analysis. Ann Allergy Asthma Immunol. 2016;116(6):544–53. 10.1016/j.anai.2016.03.030

61. Blanca-Lopez N, Andreu I, Torres Jaen MJ. Hypersensitivity reactions to quinolones. Curr Opin Allergy Clin Immunol. 2011;11(4):285–91. 10.1097/ACI.0b013e3283489bc3

62. Adefurin A, Sammons H, Jacqz-Aigrain E, Choonara I. Ciprofloxacin safety in paediatrics: A systematic review. Arch Dis Child. 2011;96(9):874–80. 10.1136/adc.2010.208843

63. Dona I, Moreno E, Perez-Sanchez N, Andreu I, Hernandez Fernandez de Rojas D, Torres M. Update on quinolone allergy. Curr Allergy Asthma Rep. 2017;17(8):56. 10.1007/s11882-017-0725-y

64. Rouzaire P, Nosbaum A, Mullet C, Diot N, Dubost R, Bienvenu F, et al. Immediate allergic hypersensitivity to quinolones associates with neuromuscular blocking agent sensitization. J Allergy Clin Immunol Pract. 2013;1(3):273–9e1. 10.1016/j.jaip.2013.02.007